These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3860370)

  • 1. [Selective cytotoxic effect of immunotoxin on erythroid tumor cells of mice].
    Tonevitskiĭ AG; Mechetner EB; Rozinova EN; Ievleva ES
    Dokl Akad Nauk SSSR; 1985; 282(2):485-8. PubMed ID: 3860370
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytotoxic properties of an immunotoxin interacting with mouse myeloma cells].
    Tonevitskiĭ AG; Trakht IN
    Dokl Akad Nauk SSSR; 1984; 277(3):756-9. PubMed ID: 6386405
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity.
    Seto M; Umemoto N; Saito M; Masuho Y; Hara T; Takahashi T
    Cancer Res; 1982 Dec; 42(12):5209-15. PubMed ID: 6814753
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibodies to antigens of mouse erythroblasts].
    Mechetner EB; Ievleva ES; Khodtsev AS; Tonevitskiĭ AG; Rozinova EN
    Dokl Akad Nauk SSSR; 1985; 282(2):476-80. PubMed ID: 2410211
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antigenic marker of human erythrokaryocytes similar to mouse erythroblastosis antigen].
    Ievleva ES; Ter-Grigorov VS; Graf IA; Pivnik AV; Idel'son LI
    Biull Eksp Biol Med; 1978 Sep; 86(9):330-2. PubMed ID: 81077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
    Tonevitskiĭ AG
    Mol Biol (Mosk); 1985; 19(4):1034-41. PubMed ID: 4047033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
    J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific cytotoxicity expressed by a conjugate of ricin and murine monoclonal antibody directed against thy 1.1 antigen.
    Houston LL; Nowinski RC
    Cancer Res; 1981 Oct; 41(10):3913-7. PubMed ID: 6116537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The demonstration of the involvement of antibody in the in vitro lysis of chicken erythrocytes by allergized spleen cells.
    Macphail S; Munro AJ
    Immunology; 1974 Dec; 27(6):1053-62. PubMed ID: 4452576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a modified plate method for determining antibody-dependent cell-mediated cytotoxicity].
    Koĭchev Ch; Mikhaĭlova S; Gencheva G; Ivanova L; Grigorova K
    Eksp Med Morfol; 1983; 22(3):49-52. PubMed ID: 6671451
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
    Seon BK
    Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates.
    Colombatti M; Colombatti A; Blythman HE; Bron C
    J Natl Cancer Inst; 1984 May; 72(5):1095-9. PubMed ID: 6585586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal immunotoxin against laryngeal carcinoma cells.
    Zenner HP
    Otolaryngol Pol; 1990; 44(3):214-5. PubMed ID: 2255554
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
    Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive cells in cancer-active immunotherapy: their cytotoxic potential and genetic restriction.
    Olsson L; Kiger N; Mathe G
    Transplant Proc; 1980 Mar; 12(1):167-71. PubMed ID: 7368287
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
    Raso V; Griffin T
    J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.